Genentech increases investment to $2bn for US manufacturing site
Roche and Genentech have a current commitment of $50bn for US manufacturing
Read More
Marketing
The latest pharma marketing news from PMLiVE.com | Pharmaceutical advertising, branding and med comms features from Communique
AstraZeneca announces $15bn investment in Chinese manufacturing and R&D by 2030
The pharma company will be the first global biopharma with end-to-end cell therapy capabilities in China
Read More
Novo Nordisk Foundation gives 736m euro grant to Denmark’s BioInnovation Institute
The funding will run until 2035 and will help the organisation to expand its presence in Europe
Read More
PMGroup Worldwide welcomes MAD World Summit
The MAD World Summit is dedicated to transforming workplace culture and employee mental health and well-being
Read More
Vibrant Therapeutics raises $61m in funding to advance intelligent therapeutics pipeline
The financing includes new investors Pfizer Ventures and Apricot Capital, bringing the total capital raised to $100m
Read More
PMLiVE’s T40 2025 – results announced!
Find out which agencies came top and which agencies are among the big climbers in this year’s list
Read More
PMEA 2025: a celebration of excellence in pharmaceutical marketing
This year’s Awards, held at the Sheraton Grand in London, included 20 categories
Read More
Smurfit Westrock unveils new clinical packaging facility at Dublin Airport
Over 40m euros was invested in the state-of-the-art adherence and clinical packaging facility
Read More
Excellence in Healthcare Partnerships Awards Networking Event
From plan to partnership: navigating the enablers and challenges of collaborative working
Read More
ISPEP launches International Patient Engagement Day 2025
The theme for this year’s global event is ‘Carry the Change’
Read More
Inizio announced as headline sponsor for 2026 Communiqué Awards
The PMGroup Awards celebrate excellence in health communications
Read More
Bioxodes appoints Philippe Monteyne as new chairman of the board
The appointment comes as the company releases phase 2a data for its intracerebral haemorrhage treatment
Read More
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- ...
- 129